An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
Condition: Peyronie's DiseaseInterventions: Biological: AA4500; Device: ErecAid® Esteem® Manual Vacuum Therapy System; Procedure: Investigator ModelingSponsor: Auxilium PharmaceuticalsRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2014 Category: Research Source Type: clinical trials
An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
Condition: Peyronie's DiseaseInterventions: Biological: AA4500; Device: ErecAid® Esteem® Manual Vacuum Therapy System; Procedure: Investigator ModelingSponsor: Endo PharmaceuticalsRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2014 Category: Research Source Type: clinical trials
Management of Peyronie's Disease With Adipose Tissue Stem Cell
Conditions: Erectile Dysfunction; Peyronie' DiseaseIntervention: Drug: Adipose tissue stem cell injectionSponsor: Man Clinic for Andrology, Male Infertility and Sexual DysfunctionRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2014 Category: Research Source Type: clinical trials
BioSpecifics Technologies Corp. Announces Online Publication in The Journal of Urology of Results from the IMPRESS Trials of XIAFLEX in Peyronie's Disease
LYNBROOK, N.Y., Feb. 4, 2013 /PRNewswire/ -- BioSpecifics
Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company
developing first in class collagenase-based products marketed as
XIAFLEX in the U.S. and XIAPEX® in Europe and Eurasia,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 5, 2013 Category: Pharmaceuticals Source Type: clinical trials
A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
Condition: Peyronie's DiseaseIntervention: Biological: AA4500Sponsor: Endo PharmaceuticalsCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2012 Category: Research Source Type: clinical trials
Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
Condition: Peyronie's DiseaseInterventions: Drug: Vitamin D2; Drug: Vitamin E; Drug: Testosterone PelletsSponsor: Men's Health BostonActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2012 Category: Research Source Type: clinical trials
A Study of AA4500 in Men With Peyronie's Disease
Condition: Peyronie's DiseaseIntervention: Biological: AA4500Sponsor: Endo PharmaceuticalsCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2010 Category: Research Source Type: clinical trials
